je.st
news
GlaxoSmithKline's experimental HIV, AIDS drug to get priority review
2013-02-19 02:02:39| Biotech - Topix.net
U.S. regulators gave priority review status to an experimental GlaxoSmithKline drug for HIV/AIDS, which industry analysts view as a possible multibillion-dollar-a-year seller.
Tags: review
drug
aids
priority
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||